bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.09.30.755370

High-resolution measurement of ERK activation state reveals determinants of BRAF regulation and drug sensitivity

Adebanjo, A. F.·Simon, J. J.·Banales Mejia, F.·Fowler, D.·Maly, D. J.
View original source ↗Export metadata ↓

Abstract

High-resolution measurements of pathway activity make it possible to characterize how signaling responds to changing cellular conditions, to evaluate pathway-targeted inhibitors, and to dissect how sequence variation shapes signaling output. Here, we describe a sequencing-based assay that uses engineered, phospho-state-selective affinity reagents to quantify ERK activation state as a high-resolution, ratiometric readout of RAS/ERK MAPK pathway activity. Profiling ~1,600 BRAF variants at basal and elevated RAS-GTP levels allowed us to assign activity scores to somatic cancer and germline RASopathy variants and to distinguish residues that stabilize autoinhibition from those required for active dimer formation. We identified a large class of dominant negative variants that suppress signaling below endogenous levels through enhanced RAS engagement and an inability to form productive RAF dimers. Measuring the intracellular potency of the RAF inhibitor LXH254 against ~1,000 variants in parallel revealed hinge and activation-loop positions conferring resistance and showed that disrupting the BRAF-MEK interface is broadly sensitizing.

Explore related subjects

cell biologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Adebanjo, A. F., Simon, J. J., Banales Mejia, F., Fowler, D., Maly, D. J.. 2026-10-02. High-resolution measurement of ERK activation state reveals determinants of BRAF regulation and drug sensitivity. https://doi.org/10.64898/2026.09.30.755370

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Non-cell-autonomous removal of protein aggregates via trogocytosis

Protein aggregate formation can cause cell damage and contribute to tissue pathologies including neurodegeneration. Protein aggregates are normally eliminated by cell-intrinsic mechanisms of lysosomal (autophagic) degradation. However, degradative capacity varies between cell types, raising the possibility that high-capacity cell types, such as macrophages, may contribute to aggregate disposal from the low-capacity cells. Here, we show that cellular protein aggregates are removed by macrophages via trogocytosis -- a partial engulfment of the target cells. Lysosomal stress upon protein aggregate accumulation promotes cell surface expression of the transmembrane isoform of the macrophage growth factor CSF1 (tmCSF1), which is detected by macrophages through the CSF1 receptor to drive trogocytosis. Insufficient or impaired degradation of protein aggregates in lysosomes results in their transport along microtubules to the plasma membrane where they physically associate with tmCSF1. This enables macrophages to specifically trogocytose protein aggregates. These findings reveal a protein homeostasis system that eliminates protein aggregates in a non-cell-autonomous manner.

cell biology↗
bioRxiv2026

STIM1 at the plasma membrane: A novel Molecular regulator of B cell migration.

Cell migration is a fundamental process required for effective immune responses, relying on both amoeboid movement and chemotaxis. Among chemotactic pathways, the CXCL12/CXCR4 axis plays a pivotal role in guiding B cell migration. While essential under physiological conditions, this pathway is frequently dysregulated in pathological contexts such as Chronic Lymphocytic Leukemia (CLL) and Systemic Lupus Erythematosus (SLE), where altered CXCR4 expression enhances B cell retention, survival, and tissue infiltration. Calcium signaling is central to B cell migration, notably through Store-Operated Calcium Entry (SOCE), STIM1 located at the endoplasmic reticulum (ER) membrane and Orai1 calcium channels. Although STIM1 is traditionally studied as an ER protein regulating SOCE, early findings and recent work from our group indicate that STIM1 is also present at the plasma membrane (STIM1PM), where it displays a dual topology and contributes to constitutive calcium entry (CCE). The function of STIM1PM pool in B cell migration remains unknown. Here, we demonstrate that both STIM1ER and Orai1 are required for CXCL12-induced migration of B cells. Importantly, we provide the first evidence that STIM1PM, exhibiting N?terminal and C?terminal orientations, actively regulates B cell migration independently of SOCE. We show that STIM1PM controls CCE and modulates intercellular interactions, thereby influencing chemotactic responses. Targeting STIM1PM domains significantly impairs B cell migration, highlighting its potential as a novel therapeutic target in diseases characterized by aberrant B cell trafficking. Our findings uncover an unanticipated role for STIM1PM and open new perspectives on calcium?dependent and calcium?independent mechanisms of B cell migration.

cell biology↗
bioRxiv2026

Disease-associated amino acid substitutions outside canonical motor motifs impair Myo1e localization and activity

Steroid-resistant nephrotic syndrome (SRNS) is a severe kidney disorder characterized by proteinuria and disruption of glomerular filtration, often driven by genetic defects in genes encoding proteins required for podocyte functions. Among these, MYO1E, encoding the actin- and membrane-associated motor protein Myosin 1e (Myo1e), has been implicated in familial and sporadic forms of SRNS. Here, we investigated two MYO1E missense variants, A92E and G562R, identified in trans in a patient with childhood-onset SRNS and located outside canonical P-loop and switch subdomains of the Myo1e motor domain. Both residues are highly conserved, located within predicted -helices in the motor domain, and replaced by larger charged residues, which may reduce protein stability or folding. In podocyte-derived cells, both mutants failed to localize at intercellular junctions and displayed reduced colocalization with actin. The G562R variant additionally formed cytoplasmic aggregates that were partially expression-level-dependent and exhibited decreased fluorescence recovery after photobleaching, indicating impaired protein dynamics. In vitro motility and ATPase assays indicated that the G562R mutant exhibited a marked loss of ATPase activity while the A92E mutant displayed ATPase activity similar to the WT but was characterized by reduced motility and thermal stability. Together, these results demonstrate that A92E and G562R mutations compromise Myo1e localization and function, supporting their pathogenic role in SRNS.

cell biology↗